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Highlights 
 
 There is considerable variation in the methods used to collect resource-use data in economic 
evaluations alongside randomized controlled trials.  We aim to improve the methods by which 
patient-reported resource use is measured. 
 A consensus process among health economists has shown that it is possible to identify a 
‘core set’ of 10 resource-use items that should be measured in almost all economic 
evaluations conducted alongside randomized controlled trials in the UK 
 The results imply that it may be feasible to develop a short, standardized resource-use 
instrument that reduces patient and researcher burden and improves comparability across 
trials, supplying healthcare decision makers with more consistent evidence on comparative 
cost-effectiveness. 
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Abstract 
 
Background: Resource-use measurement by patient recall is characterized by inconsistent methods 
and a lack of validation. A validated standardized resource-use measure could increase data quality, 
improve comparability between studies and reduce research burden. 
Aim: To identify a minimum set of core resource-use items that should be included in a standardized 
adult instrument for UK health economic evaluation from a provider perspective. 
Methods: Health economists with experience of UK-based economic evaluations were recruited to 
participate in an electronic Delphi survey. Respondents were asked to rate 60 resource-use items 
(e.g. medication names) on a scale of 1 to 9 according to the importance of the item in a generic 
context. Items considered less important according to predefined consensus criteria were dropped 
and a second survey was developed. In the second round, respondents received the median score 
and their own score from round 1 for each item alongside summarized comments and were asked to 
re-rate items.  A final project team meeting was held to determine the recommended core set. 
Results: 45 participants completed round 1. 26 items were considered less important and dropped, 
34 items were retained for the second round and no new items were added. 42 respondents 
completed round 2 (93.3%), and greater consensus was observed.  Following the final meeting, a list 
of 10 core items was selected with further items identified as suitable for ‘bolt-on’ questionnaire 
modules. 
Conclusions: The consensus on 10 items considered important in a generic context suggests that a 
standardized instrument for core resource-use items is feasible. 
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Introduction 
For cost-effectiveness analyses to be optimal, resource-use measurement in randomized controlled 
trials (RCTs) must be accurate. However, to date, considerably more research has been directed at 
improving outcome measurement methodologies (e.g. utilities) 1. The methods used to measure costs 
are poorly reported 2, and instruments to collect data directly from patients are commonly not 
validated 3 (although there are studies in which the reliability/validity of self-report is considered 4). 
Where available, routine data sources (e.g. electronic hospital records) might reduce attrition bias, be 
more accurate, and minimise the burden on trial participants. However, routine data may not be 
readily available, consistent or suitable for costing purposes 5.  Electronic systems may also be costly 
to access, and lack information on personal costs incurred by patients. It is therefore likely that 
researchers will continue to be reliant on instruments based on patient recall (e.g. diaries, logs, 
questionnaires 6) for some time, despite the fact that self-reported data on healthcare use are of 
variable accuracy 7.  
A significant amount of work in recent years has focused on developing core outcome sets (COS): 
agreed minimum sets of outcomes (often health related) to be measured and reported in all trials for a 
specific condition/treatment 8. Standardization counteracts problems with researchers selecting 
outcomes based on their own expertise or the statistical significance of results. A standard set of 
outcomes also reduces heterogeneity and improves comparability across trials 9. Although developing 
a core set of resource-use items has much in common with COS development, there are also some 
important differences. A fundamental consideration of an economic analysis is the perspective, which 
leads to the inclusion of different types of resource use. Whereas COS are specific to clinical 
conditions or treatments and are therefore different across trials, a core set of resource use is specific 
to the perspective, but could potentially be generalizable across trials. Separate measurement 
instruments may be required for outcomes identified in COS (e.g. the EQ-5D for quality of life, or the 
modified Health Assessment Questionnaire (HAQ) for patient satisfaction with activities of daily living 
10); in contrast, a core set of resource-use items would generally form a single instrument.  
Standardization of resource-use measurement is potentially controversial amongst health economists. 
Legitimate concerns about the study perspective, nature of the intervention and type of analysis 
planned may suggest that standardization is too limiting. There is a trade-off between gathering as 
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much information as possible (with increased patient burden and possible poor response rates) and 
gathering less information (which may not allow an accurate analysis to be conducted). As Drummond 
et al point out, “The skill in costing is to match the level of precision (and effort) to the importance (in 
quantitative terms) of the cost item.” 11(p253).  However, standardizing outcomes using the EQ-5D 
instrument is accepted in the UK (and indeed required by NICE 12), despite the inevitable limitation on 
the flexibility of the instrument. In contrast, health economists typically generate new, or revise 
existing, resource-use instruments for RCTs on a case-by-case basis; some standardization of cost 
measurement (albeit with ‘bolt-ons’ to ensure more complete coverage of resources) would allow 
greater comparability between trials, and would reduce the research effort required.  The significant 
overlap between questions in instruments held in the Database of Instruments for Resource-Use 
Measurement (www.dirum.org) 13 suggests that defining a core set may be feasible 14.  
In our study, we aim to identify core items of resource use that should be included in any economic 
evaluation of a healthcare intervention conducted in the UK. We aim to identify a minimum set of 
items that should be measured, and not a complete set; we anticipate health economists may 
measure additional items according to the particular nature of the RCT and perspective of the 
analysis. We use a Delphi survey to seek consensus expert opinion. 
 
Methods 
Approval for the study was granted by the Faculty of Health Sciences Research Ethics Committee of 
the University of Bristol. A patient and public involvement (PPI) representative was recruited to the 
study team via the People in Health West of England (http://www.phwe.org.uk/) mailing list. 
Phase 1: Identification of ‘long list’ and development of survey 
The identification of a ‘long list’ of resource-use items is described in detail elsewhere 14. In brief, a 
review of measurement instruments currently used in RCTs of health interventions was undertaken; 
individual items were extracted by two researchers (JT/CR) and disagreements were resolved by 
discussion. Items were scrutinized by a single researcher (RR) and overlapping items merged. Similar 
types of items were combined; for example, doctor, nurse and allied health professional were 
 
 
7 
collapsed into ‘professional seen’. Items not relevant to an NHS and personal social services (PSS) 
perspective (commonly taken in UK studies) were dropped. Remaining items were formulated as 
individual questions for a Delphi survey. The Delphi method is employed increasingly for consensus in 
core sets of outcomes 15.  It requires expert participants to provide their opinions in sequential 
questionnaires (rounds), with each round presenting group feedback from the previous round. 
Anonymity of the responses is maintained to ensure that no individual dominates the process 16. A 
web-administered ‘eDelphi’ survey was developed using REDCap electronic data capture tools 
hosted at the University of Bristol 17; items were grouped according to the location in which the care 
took place (e.g. hospital).  The survey was piloted amongst the study team, and a think-aloud web 
usability study (in which participants were asked to talk through their responses) was conducted with 
a convenience sample to ensure it was comprehensible and manageable 18.  
Phase 2: Prioritization of resource-use items 
Stakeholders 
Practising health economists with experience of RCTs in the UK were recruited to the Delphi panel. A 
generic email was sent to the Health Economists’ Study Group mailing list describing the preparatory 
work and purpose of the study and inviting participation by following a web link. Health economists 
who had recently contributed to NIHR Health Technology Assessment reports 
(http://www.journalslibrary.nihr.ac.uk/hta) or attended relevant workshops were approached directly. 
One reminder email was sent. Completion of the first questionnaire was deemed to represent 
informed consent to participate. Demographic details were requested within the survey including 
subgroups describing experience with different types of patient care (physical, mental and public 
health, older adults, primary and secondary care), length of experience and professional background. 
Survey round 1 
In round 1 of the survey, participants were asked to rate the importance of retaining each item in the 
core standardized resource-use set on a scale of 1 (not important) to 9 (very important).  Participants 
were asked to think in terms of resource use relevant to an NHS and PSS perspective for adult 
patients of any age, living with wide-ranging physical and/or mental health conditions of variable 
 
 
8 
severity (appendix 1). They were asked to assume that there may be differences between trial arms in 
any item and that they have no access to any other source of resource-use data (such as medical 
records). Participants were encouraged to comment on their ratings and suggest additional items. 
After completion of the questionnaire, items that the participant had scored 7-9 were presented back 
to them, with a request to select their ‘top 10’ items for the core set. Round 1 item scores were 
summarized across participants and items to retain for round 2 were identified using pre-specified 
criteria; items suggested by participants were added if they met pre-specified criteria (see analysis 
section).  
Survey round 2 
All participants who had completed round 1 of the survey were emailed a web link to the round 2 
questionnaire. Feedback from round 1 was presented for each round 2 item in the form of the median 
score along with a reminder of the individual’s own score.  Comments in round 1 that were relevant to 
selection choice were also summarized and presented, and changes were made to the wording for a 
small number of items based on some of the comments. Participants were asked to re-rate each item 
(appendix 1), and were given further opportunity to comment on their choices.  A reminder invitation 
was sent after two weeks, and a further reminder specifying a closing date was issued one week later. 
Shortly after the closing date, non-responders were contacted by telephone to request reasons for 
non-completion. 
Analyses 
Statistical analyses were carried out in Stata 14 (Statacorp, TX) 19, and were conducted according to 
a pre-specified analysis plan. 
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Criteria for retaining items: At the end of round 1, the percentage of participants scoring 7-9 (high 
priority) and 1-3 (low priority) was calculated for each item, both for participants overall and for each 
of the ‘type of experience’ subgroups separately. Items were retained if scored 7-9 by >50% and 1-3 
by <15% by participants overall or within two or more subgroups of participants; these pre-specified 
criteria were deliberately inclusive.  Items were also retained if ≥15% of participants prioritized the 
item in their ‘top 10’ list. Items not meeting any of these criteria were closely examined for overlap 
with retained items; if there was no overlap, the item was further considered for retention. New items 
were added to round 2 if suggested by >10% of participants. 
 
Following round 2, items were retained if scored 7-9 by >70% and 1-3 by <15% of all participants. 
Since further Delphi rounds were beyond the scope of this study, more stringent criteria were also set 
(>70% scoring an item 8 or 9 and <15% scoring 1-3) to aid discussions in a final item selection 
meeting so that a pragmatic core set could be identified. 
Attrition: Non-responders to round 2 were examined in terms of years of experience; mean scores 
were compared with those from round 2 responders. 
 
Assessment of consensus: It is not a requirement of the Delphi process to achieve consensus for 
all items (e.g. where all participants agreed on the high/low priority grouping); however, it is essential 
that participants agree a reduced number of items to be most important. It is therefore informative to 
consider the level of agreement across participants in both rounds and the degree of stability in 
scores.  
 
For each round, the percentage of participants scoring 7-9 and 1-3 was examined for evidence of 
bimodality (defined as >40% rating an item 7-9 and >40% rating it 1-3) for each item, as this could 
indicate an irreconcilable difference of opinion.  The intraclass correlation coefficient (ICC, two-way 
random effects model) was calculated for both rounds, to give an indication of agreement within the 
survey. 20 
For each item, the mean absolute change in score between rounds was also calculated; a large 
change (defined as ≥3 points) could indicate instability.  The percentage of people changing their 
 
 
10 
score by a small amount (1 or 2 points) and a large amount (≥3 points) was calculated for each item 
to give an indication of the stability of the results.  Variation in changes to scores with length of 
experience (categorized as <5 years, 5-10 years, 10-20 years and >20 years) was explored through 
linear regression.  Finally, the standard deviation of scores was calculated for each item (separately 
for each round) as a measure of the spread in responses across participants (and degree of 
agreement), and used to calculate the change in each item’s variability between rounds 21.   
Analysis of comments: Content analysis (a systematic approach to studying text that aims to 
categorize and quantify content) was conducted for comments using nVivo software 22,23.  
Suggestions in round 1 for new items were extracted, and broad themes were identified for both 
rounds.   
 
Phase 3: Final item selection meeting 
The project team met to determine the final core items to include in a standardized ‘short form’ 
resource-use measure.  Participants who had commented extensively during the Delphi process or 
were associated with the MRC Network of Hubs for Trials Methodology Research were invited to 
attend the meeting. Each item included in round 2 was discussed in detail. The two pre-specified 
criteria were applied to the round 2 data to identify the items considered most crucial (more stringent 
criteria) and very important (less stringent criteria) for inclusion in the final core set. Items reaching the 
more stringent criteria were included in the final set if considered relevant, by the team, to all trials 
and patient populations. If relevant only to specific settings, items were included in suggested bolt-on 
modules. Items reaching the less stringent criteria were then discussed and merged with those 
already in the final set where appropriate, or considered as separate items for the core set or as items 
within bolt-on modules. Remaining items were examined to ensure that nothing vital was overlooked.  
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Results 
Phase 1 
Items were extracted from 59 resource-use instruments.  Following the deduplication and merging 
processes, the ‘long list’ contained 60 items, categorized as hospital care (n=15), emergency care 
(n=5), care at a GP surgery or health clinic (n=7), care at home (n=7), remote access care (n=4), 
other community care (n=6), residential care (n=10) and medication (n=6). Usability studies with both 
a native and a non-native English speaker indicated that the Delphi survey was comprehensible, and 
completion was manageable. 
Phase 2  
45 participants provided usable responses to round 1; 41 completed the whole survey, while 4 
supplied ratings for all items, but did not select their ‘top 10’ (figure 1). Participants with a range of 
experience were represented (table 1), although almost all were working in academia (n=42/45). 
Applying the predefined consensus criteria identified 27 items to be retained for round 2, considered 
to be of high priority by participants overall. Four additional items were considered important by ≥2 
subgroups: minor surgery (important to participants with experience of primary care, physical health, 
public health or older adults), living in either a residential home or supported accommodation (rated 
highly by participants with experience of primary care, mental health or older adults), and the period 
over which medication is taken (important to respondents with experience in primary care and public 
health). Type of ward and scans were added because >15% of respondents cited it in their top 10. 
Finally, equipment was identified as a suitable addition because it came close to meeting several of 
the above criteria and no other similar items were included. No new items met the inclusion criteria. 
34 items were therefore included for round 2 (table 2a) and 26 were dropped (table 2b). Engagement 
with the project in round 1 was good, with broadly positive comments indicating that achieving 
consensus was feasible. 
42/45 participants (93.3%) responded to round 2 (figure 1). The three non-responders each came 
from a different level of experience. Non-responders had a mean(SD) score of 8.53(0.33) in round 1 
compared with 7.13(1.09) for responders (p=0.03). There was no evidence of bimodality for any item 
in either round. All responding participants changed at least one rating between rounds, and all items 
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were changed by at least one participant. Participants changed their scores by a mean(SD) of 
0.70(0.36) points between rounds. 
The ICC (95% CI) increased from 0.85 (0.77-0.91) in round 1 to 0.93 (0.89-0.96) in round 2, 
suggesting increased consensus in round 2.  Between rounds, standard deviations reduced for all 
individual items except hospital admission items and prescribed medication (table 3), again 
suggesting movement towards increased consensus in round 2.  As anticipated, 100% concordance 
on the priority group (high/low) was not achieved for any item in either round. No relationship was 
observed between changes to mean scores and length of experience.  
28 respondents commented in round 1, with two not completing the survey. The content analysis 
showed that the hospital and home care categories attracted the highest number of comments (15 
and 11, respectively). Some comments indicated that the task was cognitively challenging. The most 
common theme was that the inclusion of a particular item depended on another factor including 
perspective, intervention, setting, condition, patient group, level of detail, recall period, time horizon 
and comparator.  Potential issues with patient recall and practical aspects of administering a 
resource-use questionnaire were also raised.  17 respondents commented in round 2; comments 
largely focused on useful suggestions for developing an instrument, with 7 individuals suggesting a 
modular approach. 
Phase 3 
In addition to the project team, three Delphi participants were invited to attend the final item selection 
meeting; owing to other commitments, only one was available.  The selection group identified 
community healthcare questions that could be combined with GP questions for consistency. Items 
asking about details of hospital operations or procedures were considered less important by the more 
stringent set of consensus rules, and were rejected for the core set of items for the ‘short form’ (table 
4). These items could be included in an extended hospital care module for trials where admissions (or 
re-admissions) for procedures are prevalent. Similarly, most residential care items (with the exception 
of hospice stays) did not meet the stringent consensus rules. While residential care was thought to be 
extremely important in some trials, it was judged by the selection meeting group to be not relevant in 
the majority, and was therefore identified as a suitable candidate for a bolt-on module. Items on social 
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care did not meet the more stringent consensus rules, potentially because they were considered to be 
more relevant to particular groups, such as older adults; these items could therefore be included in a 
bolt-on social care module. Perhaps surprisingly, items on medication use were not identified as 
important by the more stringent criterion rules. The selection committee group felt that medication use 
was relevant to participants in the majority of trials, and should therefore remain on the included list; 
however, future work will look at the practical aspects of collecting medication data, and medication 
may form a separate module in the future.   
 
Discussion 
Based on consensus amongst health economists, we have identified a minimum core set of 10 
resource-use items that should be considered for inclusion in a standardized questionnaire for 
patients (table 5).  We have identified additional items that are suitable for inclusion as ‘bolt-on’ or 
extended modules covering further details about hospital procedures, residential care and social care. 
Agreement amongst participants was excellent 24 and moved towards consensus in the second round. 
Results were reasonably stable, suggesting that a third round would not have significantly altered the 
outcome. Although the survey was conducted from the viewpoint of the NHS and PSS, the key 
inclusions are all items commonly provided by the NHS. Social services care could therefore form a 
separate bolt-on module for trial populations where it is thought to be prevalent.  
 
Knapp and Beecham 25 identified ‘reduced lists’ of key services that could be measured to capture 
over 90% of the total costs of health and social care in patient groups with mental health conditions. 
The study indicated that, in principle, capturing a fairly small number of key items of resource use can 
lead to adequate cost information, with diminishing returns gained by further data collection. However, 
while there was some overlap with the items we identified in this study (hospital inpatient and 
outpatient, residential care and GP care), the nature of the patient group meant that social services 
played a considerably more prominent role.   
Generic resource-use measures developed to date include the Annotated Patient Cost Questionnaire 
(APCQ) 26, and the Client Service Receipt Inventory (CSRI) 27. The APCQ was designed as a generic 
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patient-reported instrument. Although empirical evidence suggests the questionnaire performs well 28, 
it has not been widely adopted (possibly due to the length of the questionnaire necessitating 
substantial work to generate an instrument for a trial). The CSRI has been tested extensively, 
demonstrating good consistency, reliability and validity 29-32 and is well used. However, it was 
developed in the context of psychiatric care, was designed for interview administration rather than 
patient self-completion and has been subject to uncontrolled modification over the years. 
Standardization of data collection has also been attempted in the context of cancer care 33, and a 
generic Dutch-language instrument has been developed 34. However, neither implementation 
combines full standardization across all disease areas with a concise instrument, and neither 
attempted to determine relevant content through a documented consensus process involving health 
economists.  
Strengths of the study include the recruitment of the panel of expert participants, who were 
representative of a wide range of experience and had extensive NHS research experience. The 
stability of the panel was good with less than 10% attrition, and the study benefited from patient 
involvement in the study team.  Established methods for conducting Delphi surveys were followed, 
with consensus criteria defined in advance of conducting each round. There was clear consensus for 
items ultimately included in the core set.  However, there may also be some limitations.  Almost all of 
the respondents came from an academic background; wider participation from industry 
representatives may have been beneficial in terms of generalizability, although their experience of 
NHS research would have been more limited. A larger sample participating in the Delphi survey would 
have been preferable; however, there is no statistical basis on which to determine necessary sample 
size for a Delphi survey and previous studies including fewer participants have been shown to 
produce reliable results 35.  Respondents were asked to rate both type of resource use (e.g. hospital 
or GP care) and measurement information (such as the number of nights or appointments) 
simultaneously. The task was therefore cognitively challenging, with a large set of factors to bear in 
mind while responding; it is possible that participants may not have taken everything relevant into 
account.  
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The items identified are those considered most important by professional health economists for 
inclusion in a core set of resource-use items. Work is now needed to identify the most appropriate 
way to measure these items to ensure patient acceptability and comprehensibility. There was 
evidence from the comments that some participants were considering patient ability to respond to 
questions. For example, one respondent commented that “…many patient groups are very confused 
about which services and professionals have visited them at home”.  This requires further 
investigation with patient groups. Patients were not recruited to the Delphi panel, as the task was not 
meaningful in the context of the UK healthcare system in which patients do not pay for services at the 
point of use. However, the patient perspective was represented during the study by the PPI member 
of the project team.  Translation of the questionnaire to other languages (and other healthcare 
systems) also requires further investigation; given the common nature of the items included, it is 
possible that it will extend readily to other healthcare systems. 
 
In this project, we have focused on an NHS and PSS perspective. There will commonly be 
requirements for additional data to be collected; any future instrument should take this into account 
through modularization, allowing modifications in a controlled fashion only, with alterations recorded. 
It is also likely that the resource use associated with the intervention itself will need to be collected 
separately.  The developed instrument should be reviewed regularly to ensure that it remains current; 
for example, remote-access care does not feature in our short form, but may become more pertinent 
in future if online consultations become common.  We plan to develop a core module based on the 10 
items identified in this study, working with PPI representatives to convert the items into questions that 
are meaningful and straightforward to answer.  
 
Conclusions 
The consensus on which items are important to health economists working on clinical trials in a 
generic context suggests that a standardized instrument for core items is feasible. The list of items 
identified forms a coherent set that is potentially relevant to most trials, conditions and patient groups; 
it is therefore suitable for further development into a flexible instrument with additional extended and 
‘bolt-on’ modules. Collecting cost data in a manner that is simultaneously concise, understandable for 
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patients, valid, precise, consistent between trials, and generalizable is challenging. We have provided 
much needed evidence that it may be possible to develop a standardized instrument that goes some 
way to meeting those challenges, based on the most important cost items. 
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Table 1. Characteristics of 45 Delphi participants from round 1. 
 N (%) 
Years of experience  
 <5 years 11 (24.4%) 
 5-10 years 12 (26.7%) 
 10-20 years 11 (24.4%) 
 >20 years 11 (24.4%) 
Trial experience  
 Adults 44 (97.8%) 
 Children 21 (46.7%) 
 Older adults 26 (57.8%) 
 Physical health conditions 38 (84.4%) 
 Mental health conditions 28 (62.2%) 
 Public health interventions 20 (44.4%) 
 Primary care 33 (73.3%) 
 Secondary care 39 (86.7%) 
Background  
 Academia 42 (93.3%) 
 Other   3 (6.7%) 
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Table 2a. Items retained at the end of round 1. 
Item description 
% rating 
7-9 
% rating 
1-3 
Median 
(IQR)  
Inclusion 
reason 
HOSPITAL CARE:     
(1) Number of hospital admissions (inpatient stay or day 
case) 
95.56 0.00 9(9-9) consensus 
(2) Number of hospital outpatient appointments 91.11 2.22 9(8-9) consensus 
(3) Length of stay (e.g. dates or number of nights) 84.44 0.00 9(8-9) consensus 
(4) Number of operations/procedures undergone 64.44 4.44 8(6-9) consensus 
(5) Type of operation/procedure undergone 64.44 4.44 8(6-9) consensus 
(6) Type of professional seen (e.g. consultant/nurse) 53.33 13.33 7(5-8) consensus 
(7) Number of imaging scans undergone (e.g. X-ray/MRI) 42.22 13.33 6(5-8) top 10 a 
(8) Type of ward stayed in 37.78 11.11 6(5-8) top 10 a 
EMERGENCY CARE:     
(9) Number of visits to accident and emergency 91.11 0.00 9(7-9) consensus 
(10) Number of admissions to hospital, after A&E 80.00 2.22 9(7-9) consensus 
(11) Number of times paramedic care received 53.33 4.44 7(5-9) consensus 
CARE AT A GP SURGERY or HEALTH CLINIC:     
(12) Number of appointments at GP surgery or health 
clinic 
95.56 2.22 9(9-9) consensus 
(13) Type of professional seen (e.g. GP/nurse/counsellor) 80.00 0.00 9(7-9) consensus 
(14) Number of minor surgery/procedures/treatments 
undergone 
46.67 6.67 6(5-9) 
subgroup 
b  
CARE AT HOME:     
(15) Number of healthcare or social care professional 
visits at home (e.g. health visitor/GP) 
86.67 2.22 9(8-9) consensus 
(16) Type of professional seen at home 80.00 0.00 9(7-9) consensus 
(17) Number of professional visits for help with daily 
activities (e.g. washing/dressing) 
55.56 6.67 7(5-9) consensus 
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(18) Equipment (e.g. wheelchairs/portable 
oxygen/specialist clothing) or home adaptation (e.g. grab 
rails/ramp) supplied 
44.44 13.33 6(5-8) close c 
REMOTE ACCESS CARE:     
(19) Number of real time telephone/computer contacts 
with health or social care professional (e.g. with GP or 
telephone helpline) 
68.89 4.44 7(6-9) consensus 
(20)Type of professional contacted (e.g. 
doctor/nurse/social worker) 
53.33 6.67 7(5-9) consensus 
OTHER COMMUNITY CARE:     
(21) Number of visits to healthcare professional in the 
community (e.g. dentist, pharmacist, nurse, counsellor, 
therapist) 
80.00 2.22 9(7-9) consensus 
(22) Number of visits to social care professional in the 
community (e.g. social worker/housing worker/drug and 
alcohol worker) 
75.56 2.22 9(7-9) consensus 
(23) Type of healthcare professional seen 71.11 4.44 8(5-9) consensus 
(24) Type of social care professional seen in the 
community 
62.22 4.44 8(5-9) consensus 
RESIDENTIAL CARE:     
(25) Stay in hospice 77.78 6.67 9(7-9) consensus 
(26) Length of time spent in the hospice 75.56 8.89 8(7-9) consensus 
(27) Use of short-term respite or rehabilitation care 66.67 6.67 7(5-9) consensus 
(28) Length of stay in short term respite or rehabilitation 
care 
62.22 8.89 7(5-9) consensus 
(29) Living in a nursing home 53.33 11.11 7(5-9) consensus 
(30) Living in a residential home 48.89 11.11 6(5-9) 
subgroup 
b 
(31) Living in supported accommodation/sheltered 
housing 
46.67 11.11 6(5-9) 
subgroup 
b 
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MEDICATION:     
(32) Number of prescribed medications 68.89 6.67 8(5-9) consensus 
(33) Name of medication 64.44 4.44 8(5-9) consensus 
(34) Period taken for (e.g. dates or number of days) 46.67 11.11 6(5-9) 
subgroup 
b 
 
a Item included because >15% of participants listed it in their ‘top 10’ choice. b Item included because 
>1 subgroup rated it highly. c Item included because it came close to meeting several criteria. 
 
Table 2b. Items dropped at the end of round 1. 
Item description 
% 
rating 
7-9 
% 
rating 
1-3 
Median 
(IQR)  
HOSPITAL CARE:    
Number of other procedures undergone 35.56 20.00 6(4-7) 
Number of laboratory tests undergone 35.56 24.44 5(4-7) 
Type of imaging scans undergone 31.11 15.56 6(5-8) 
Type of other procedures undergone 26.67 17.78 5(4-7) 
Type of laboratory tests undergone 22.22 26.67 5(3-6) 
Length of outpatient appointment 15.56 55.56 3(2-5) 
Number of hospital transport journeys (non-emergency) 13.33 42.22 5(2-5) 
EMERGENCY CARE:    
Number of ambulance journeys 28.89 17.78 5(4-7) 
Time spent in accident and emergency 15.56 46.67 4(3-5) 
CARE AT A GP SURGERY or HEALTH CLINIC:    
Number of laboratory tests undergone 40.00 22.22 5(4-7) 
Type of minor surgery/procedures/treatments undergone 33.33 11.11 5(5-7) 
Timing of appointments (office hours or out of hours) 33.33 31.11 5(3-9) 
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Type of laboratory tests undergone 26.67 28.89 5(3-7) 
CARE AT HOME:    
Type of equipment or adaptation supplied 35.56 22.22 5(4-7) 
Time spent with professional at home 33.33 22.22 5(4-7) 
Time spent by professional for help with daily activities 31.11 15.56 5(5-7) 
REMOTE ACCESS CARE:    
Duration of contact with professional 24.44 33.33 5(3-6) 
Number of email or SMS (Text) communications with 
healthcare professional 
13.33 42.22 4(3-5) 
OTHER COMMUNITY CARE:    
Use of patient support services in the community (e.g. 
self-help groups/lunch clubs/day centre) 
28.89 15.56 5(4-7) 
Type of support service used 24.44 22.22 5(4-6) 
RESIDENTIAL CARE:    
Date moved to nursing home 46.67 13.33 6(5-9) 
Date moved to residential home 42.22 13.33 6(5-9) 
Date moved to supported accommodation/sheltered 
housing 
40.00 13.33 5(5-9) 
MEDICATION:    
Frequency taken 42.22 15.56 6(5-9) 
Dose taken 42.22 15.56 5(5-9) 
Route taken (e.g. oral/suppository/intravenous) 24.44 35.56 5(3-6) 
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Table 3. Indicators of response to feedback from round 1. 
 
 Mean (SD) 
Round 2 minus 
Round 1 
% rating an 
item 7-9 
% changing 
score by 
Item description 
Round 
1 
Round 
2 
Change 
in mean  
Change 
in SD 
Round 
1 
Round 
2 
1 or 2  >=3  
GP appointments 8.5(1.1) 8.7(0.9) 0.13 -0.23 95.56 97.62 21.43 0.00 
GP 
surgery/procedure 
6.3(2.1) 5.8(1.9) -0.52 -0.25 46.67 35.71 52.38 2.38 
GP prof. seen 7.9(1.5) 8.2(1.2) 0.30 -0.35 80.00 92.86 23.81 2.38 
Equipment 6.1(2.2) 6.0(1.7) -0.13 -0.48 44.44 33.33 45.24 4.76 
Home visits 8.3(1.3) 8.5(0.8) 0.19 -0.49 86.67 97.62 11.90 2.38 
Help with activities 6.9(2.1) 6.8(1.5) -0.13 -0.58 55.56 59.52 59.52 4.76 
Prof. seen at home 7.8(1.6) 8.0(1.4) 0.20 -0.23 80.00 88.10 21.43 7.14 
Admissions after 
A&E 
7.8(1.7) 7.9(1.8) 0.06 0.06 80.00 88.10 21.43 16.67 
Paramedic care 6.8(2.0) 6.7(1.3) -0.07 -0.68 53.33 50.00 52.38 7.14 
A&E 8.2(1.2) 8.5(0.8) 0.25 -0.40 91.11 95.24 26.19 2.38 
Length of stay 8.2(1.5) 8.4(1.4) 0.20 -0.02 84.44 92.86 23.81 2.38 
Hospital admissions 8.7(0.8) 8.6(1.2) -0.14 0.38 95.56 97.62 9.52 2.38 
Hospital outpatients 8.2(1.5) 8.5(0.9) 0.21 -0.52 91.11 97.62 26.19 2.38 
Imaging scans 6.2(2.3) 5.6(1.8) -0.58 -0.51 42.22 23.81 33.33 9.52 
Operation/procedure 7.2(2.1) 7.5(1.4) 0.28 -0.75 64.44 78.57 45.24 7.14 
Speciality/ward 6.2(2.0) 6.1(1.7) -0.08 -0.26 37.78 38.10 45.24 7.14 
Operation type 7.1(2.0) 7.3(1.4) 0.17 -0.59 64.44 71.43 35.71 7.14 
Prof. seen outpatient 6.2(2.2) 6.4(1.7) 0.16 -0.49 53.33 57.14 47.62 7.14 
Name of medication 7.1(2.1) 7.3(1.9) 0.17 -0.20 64.44 73.81 42.86 14.29 
Prescribed 
medication 
7.2(2.3) 6.7(2.3) -0.51 0.03 68.89 64.29 35.71 9.52 
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Period taken for 6.4(2.3) 6.3(1.8) -0.09 -0.41 46.67 40.48 42.86 9.52 
Community 
healthcare  
7.8(1.7) 8.1(1.3) 0.29 -0.41 80.00 88.10 33.33 4.76 
Community social 
care  
7.7(1.8) 8.0(1.2) 0.22 -0.55 75.56 85.71 35.71 4.76 
Health prof. seen 7.2(2.0) 7.5(1.5) 0.30 -0.56 71.11 78.57 33.33 7.14 
Social care prof. 
seen 
7.0(2.2) 7.4(1.6) 0.38 -0.56 62.22 73.81 35.71 9.52 
Tel/computer 
contacts 
7.2(1.9) 7.0(1.5) -0.27 -0.43 68.89 64.29 50.00 2.38 
Professional 
contacted 
6.6(2.0) 6.8(1.5) 0.16 -0.51 53.33 54.76 52.38 2.38 
Respite length of 
stay  
6.9(2.3) 6.7(1.9) -0.24 -0.36 62.22 64.29 57.14 2.38 
Hospice length of 
stay 
7.4(2.1) 7.4(2.1) -0.02 -0.02 75.56 78.57 33.33 7.14 
Nursing home 6.8(2.4) 6.6(2.0) -0.14 -0.42 53.33 57.14 57.14 4.76 
Residential home 6.7(2.4) 6.2(2.1) -0.50 -0.28 48.89 40.48 42.86 11.90 
Supported 
accommodation 
6.4(2.5) 5.9(2.0) -0.52 -0.52 46.67 30.95 40.48 9.52 
Stay in hospice 7.5(2.1) 7.6(2.1) 0.13 -0.05 77.78 80.95 19.05 11.90 
Respite care 7.0(2.2) 6.9(1.9) -0.16 -0.32 66.67 73.81 47.62 7.14 
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Table 4. Final outcomes for items following round 2. 
Item description 
% 
rating 
7-9 
% 
rating 
8 or 9 
% 
rating 
1-3 
Outcome: 
pre-agreed 
rules 
Outcome: 
more 
stringent 
rules 
Final outcome 
following item 
selection 
meeting 
Hospital outpatients 97.62 80.95 0.00 include include Short form 
Hospital admissions 97.62 90.48 2.38 include include Short form 
Length of stay 92.86 85.71 2.38 include include Short form 
Operation/procedure 78.57 61.90 0.00 include exclude 
Extended hospital 
care module 
Operation type 71.43 54.76 0.00 include exclude 
Extended hospital 
care module 
A&E 95.24 88.10 0.00 include include Short form 
Admissions after A&E 88.10 76.19 7.14 include include Short form 
GP appointments 97.62 95.24 0.00 include include Short form 
GP prof. seen 92.86 78.57 0.00 include include Short form 
Home visits 97.62 85.71 0.00 include include Short form 
Prof. seen at home 88.10 69.05 2.38 include exclude Short form 
Community healthcare  88.10 78.57 2.38 include include 
Combined with 
GP appointments 
in short form 
Community social care  85.71 69.05 0.00 include exclude 
Social care 
module 
Health prof. seen 78.57 57.14 2.38 include exclude 
Combined with 
GP appointments 
in short form 
Social care prof. seen 73.81 52.38 2.38 include exclude 
Social care 
module 
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Stay in hospice 80.95 73.81 9.52 include include 
Residential care 
module 
Hospice length of stay  78.57 66.67 11.90 include exclude 
Residential care 
module 
Respite care 73.81 40.48 7.14 include exclude 
Residential care 
module 
Name of medication 73.81 59.52 4.76 include exclude Short form 
Prof. seen outpatient 57.14 26.19 4.76 exclude exclude  
Speciality/ward 38.10 16.67 9.52 exclude exclude  
Imaging scans 23.81 11.90 9.52 exclude exclude  
Paramedic care 50.00 23.81 0.00 exclude exclude  
GP surgery/procedure 35.71 16.67 9.52 exclude exclude  
Help with activities 59.52 30.95 2.38 exclude exclude  
Equipment 33.33 21.43 2.38 exclude exclude  
Tel/computer contacts 64.29 38.10 2.38 exclude exclude  
Professional contacted 54.76 35.71 2.38 exclude exclude  
Respite length of stay  64.29 40.48 7.14 exclude exclude  
Nursing home 57.14 35.71 9.52 exclude exclude  
Residential home 40.48 28.57 11.90 exclude exclude  
Supported 
accommodation 
30.95 19.05 11.90 exclude exclude  
Prescribed medication 64.29 47.62 14.29 exclude exclude  
Period taken for 40.48 28.57 4.76 exclude exclude  
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Table 5. Items included in final core set. 
 Type of care Item 
1 HOSPITAL CARE  Number of hospital admissions (inpatient stay or day case) 
2 HOSPITAL CARE  Length of stay (e.g. dates or number of nights) 
3 HOSPITAL CARE Number of hospital outpatient appointments 
4 EMERGENCY CARE Number of visits to accident and emergency 
5 EMERGENCY CARE Number of admissions to hospital, after accident and emergency 
6 CARE AT A GP 
SURGERY OR HEALTH 
CLINIC OR OTHER 
COMMUNITY SETTING  
Number of appointments 
7 CARE AT A GP 
SURGERY OR HEALTH 
CLINIC OR OTHER 
COMMUNITY SETTING 
Type of professional seen 
8 HEALTHCARE AT HOME Number of healthcare professional visits at home 
 
9 HEALTHCARE AT HOME Type of healthcare professional seen at home 
 
10 MEDICATION 
 
Name/class of medication 
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Figure 1. Flow of Delphi study participants through study. 
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Appendix 1. Delphi survey instructions  
Figure A1.  Instructions for round 1. 
 
 
 
 
 
 
 
 
 
Figure A2. Instructions for round 2. 
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